Koyfin Home > Directory > Health Care > Revance Therapeutics > EV / Sales (ltm)

Revance Therapeutics EV / Sales (ltm) Chart (RVNC)

Revance Therapeutics annual/quarterly EV / Sales (ltm) from 2014 to 2019.
  • Revance Therapeutics EV / Sales (ltm) for the quarter ending November 11, 2019 was 154.78 a 3.10% increase of 4.80 year over year
  • Revance Therapeutics EV / Sales (ltm) for the last 12 months ending November 11, 2019 was 154.78 a 3.10% increase of 4.80 year over year
  • Revance Therapeutics Annual EV / Sales (ltm) for 2019 was 154.78 a 0.91% increase of 1.41 from 2018
  • Revance Therapeutics Annual EV / Sales (ltm) for 2019 was 153.37 a -0.28% decrease of -0.42 from 2018
  • Revance Therapeutics Annual EV / Sales (ltm) for 2019 was 153.79 a 2.48% increase of 3.81 from 2018
Other Valuation Metrics:
  • Revance Therapeutics Market Cap for the quarter ending March 03, 2018 was $1,131m a 29.36% increase of 332m year over year
  • Revance Therapeutics Price / Book for the quarter ending March 03, 2018 was 4.18 a -6.42% decrease of -0.27 year over year
  • Revance Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $850m a 27.67% increase of 235m year over year
View Chart On Koyfin

Quarterly RVNC EV / Sales (ltm) Data

11/2019154.78
10/2019153.37
10/2019153.79
10/2019149.98
10/2019147.59
10/2019149.42
10/2019147.44
10/2019149.70
10/2019147.73
10/2019153.51

Annual RVNC EV / Sales (ltm) Data

2019154.78
2019153.37
2019153.79
2019149.98
2019147.59
2019149.42
2019147.44
2019149.70
2019147.73
2019153.51